Biliary tract cancer drug Durvalumab approval key opportunity for AstraZeneca in India: GlobalData
Imfinzi is the only immunotherapy-based combination treatment option in India that offers significantly improved survival rates in…
Recover your password.
A password will be e-mailed to you.
Recover your password.
A password will be e-mailed to you.